FDA Races to Keep Up with Misleading Drug Ads. Julie Schmit.
by Schmit, Julie; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 74Business. Publisher: USA Today, 2005ISSN: 1522-3191;.Subject(s): Advertising -- Drugs | Pharmaceutical industry | United States Food and Drug Adm | VioxxDDC classification: 050 Summary: "Stop misleading the public. Tell the truth. The FDA is firing that doubled-barreled commandment more often when it spots misleading promotions for prescription drugs, a sign the agency is getting tougher on what the pharmaceutical industry does with the $9 billion a year it spends on marketing to consumers and doctors." (USA TODAY) The article discusses the FDA's tougher enforcement of drug marketing.Item type | Current location | Call number | Status | Date due |
---|---|---|---|---|
Books | High School - old - to delete | REF SIRS 2006 Business Article 74 (Browse shelf) | Available |
Browsing High School - old - to delete Shelves Close shelf browser
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
REF SIRS 2006 Business Article 71 E-Commerce Gets Smarter. | REF SIRS 2006 Business Article 72 The Idiot Consumer. | REF SIRS 2006 Business Article 73 Why Medical Malpractice Caps Are Wrong. | REF SIRS 2006 Business Article 74 FDA Races to Keep Up with Misleading Drug Ads. | REF SIRS 2006 Business Article 74 The Big Pill Pitch. | REF SIRS 2006 Business Article 74 New Drug Ad Guidelines Unlikely to Satisfy. | REF SIRS 2006 Business Article 75 Consumer Vertigo. |
Articles Contained in SIRS Enduring Issues 2006.
Originally Published: FDA Races to Keep Up with Misleading Drug Ads, May 30, 2005; pp. n.p..
"Stop misleading the public. Tell the truth. The FDA is firing that doubled-barreled commandment more often when it spots misleading promotions for prescription drugs, a sign the agency is getting tougher on what the pharmaceutical industry does with the $9 billion a year it spends on marketing to consumers and doctors." (USA TODAY) The article discusses the FDA's tougher enforcement of drug marketing.
Records created from non-MARC resource.
There are no comments for this item.